ES2109412T3 - (-)-cimaterol en esencia opticamente puro y sus sales por adicion de acidos, asi como su empleo como medicamento o favorecedor del rendimiento. - Google Patents

(-)-cimaterol en esencia opticamente puro y sus sales por adicion de acidos, asi como su empleo como medicamento o favorecedor del rendimiento.

Info

Publication number
ES2109412T3
ES2109412T3 ES93117935T ES93117935T ES2109412T3 ES 2109412 T3 ES2109412 T3 ES 2109412T3 ES 93117935 T ES93117935 T ES 93117935T ES 93117935 T ES93117935 T ES 93117935T ES 2109412 T3 ES2109412 T3 ES 2109412T3
Authority
ES
Spain
Prior art keywords
cimaterol
salts
medication
essence
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93117935T
Other languages
English (en)
Inventor
Wolfgang Dr Dipl-Chem Resemann
Adolf Durr
Gunther Prof Dr Engelhardt
John Francis Dr Quirke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica GmbH, Boehringer Ingelheim Vetmedica Inc filed Critical Boehringer Ingelheim Vetmedica GmbH
Application granted granted Critical
Publication of ES2109412T3 publication Critical patent/ES2109412T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms

Abstract

EL INVENTO SE REFIERE A LA APLICACION DE (-)-CIMATEROL Y SUS SALES DE ADICION DE ACIDO COMO MEDICAMENTO O INCREMENTADOR DE RENDIMIENTO.
ES93117935T 1990-05-04 1991-04-26 (-)-cimaterol en esencia opticamente puro y sus sales por adicion de acidos, asi como su empleo como medicamento o favorecedor del rendimiento. Expired - Lifetime ES2109412T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014252A DE4014252A1 (de) 1990-05-04 1990-05-04 Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Publications (1)

Publication Number Publication Date
ES2109412T3 true ES2109412T3 (es) 1998-01-16

Family

ID=6405664

Family Applications (2)

Application Number Title Priority Date Filing Date
ES93117935T Expired - Lifetime ES2109412T3 (es) 1990-05-04 1991-04-26 (-)-cimaterol en esencia opticamente puro y sus sales por adicion de acidos, asi como su empleo como medicamento o favorecedor del rendimiento.
ES91106774T Expired - Lifetime ES2075255T3 (es) 1990-05-04 1991-04-26 Separacion en enantiomeros de cimaterol.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES91106774T Expired - Lifetime ES2075255T3 (es) 1990-05-04 1991-04-26 Separacion en enantiomeros de cimaterol.

Country Status (27)

Country Link
US (4) US5248695A (es)
EP (2) EP0589488B1 (es)
JP (1) JP2944777B2 (es)
KR (1) KR0183024B1 (es)
AR (1) AR247728A1 (es)
AT (2) ATE124932T1 (es)
AU (1) AU645313B2 (es)
BG (1) BG60743B1 (es)
CA (1) CA2041818C (es)
CZ (1) CZ286389B6 (es)
DE (3) DE4014252A1 (es)
DK (2) DK0589488T3 (es)
ES (2) ES2109412T3 (es)
FI (1) FI109600B (es)
GR (2) GR3017064T3 (es)
HU (1) HU214335B (es)
ID (1) ID966B (es)
IE (2) IE80651B1 (es)
IL (1) IL98030A (es)
NO (1) NO174803B (es)
NZ (1) NZ238032A (es)
PT (1) PT97544B (es)
RU (1) RU2002737C1 (es)
SG (1) SG45439A1 (es)
SK (1) SK279258B6 (es)
TW (1) TW197415B (es)
ZA (1) ZA913337B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
WO1997026871A1 (en) * 1996-01-29 1997-07-31 Savor, Evelyn Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists
EP1787529A3 (en) * 1997-04-30 2009-11-18 Courage Corporation Pty Ltd. Composition and methods using an eutomer
JP2001527545A (ja) 1997-04-30 2001-12-25 ブリッジ ファーマ，インコーポレーテッド ユートマーを使用する組成物および方法
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
BR0110331A (pt) * 2000-04-27 2003-01-07 Boehringer Ingelheim Pharma Substâncias que mimetizam beta que têm uma atividade de longa duração, processos para prepará-las e o uso das mesmas como medicamentos
US20030162459A1 (en) * 2002-02-27 2003-08-28 Osbon Robert Lindsay Method for producing a nonwoven fabric with enhanced characteristics
US20040235922A1 (en) * 2003-05-15 2004-11-25 Baile Clifton A. Compositions and methods for inducing adipose tissue cell death
ES2297461T3 (es) 2003-09-09 2008-05-01 Fumapharm Ag Uso de derivados del acido fumarico para tratar la insuficiencia cardiaca y el asma.
SG124283A1 (en) * 2004-03-24 2006-08-30 Trusted Hub Ltd Document signature method & system
WO2006108424A2 (en) 2005-04-13 2006-10-19 Astion Pharma A/S Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
WO2006128180A2 (en) * 2005-05-27 2006-11-30 Children's Medical Center Corporation Methods for the treatment of disease
WO2006138243A2 (en) * 2005-06-13 2006-12-28 University Of Vermont And State Agricultural College Inhibition of creatine uptake to promote weight loss
AU2013353723B2 (en) 2012-12-03 2018-02-22 Pfizer Inc. Novel selective androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136601C (es) * 1967-06-15
US4119710A (en) * 1972-12-18 1978-10-10 Boehringer Ingelheim Gmbh Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4814350A (en) * 1986-09-10 1989-03-21 American Cyanamid Company Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile
US4792546A (en) * 1986-12-05 1988-12-20 American Cyanamid Company Method for increasing weight gains and reducing deposition of fat in animals
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Also Published As

Publication number Publication date
AR247728A1 (es) 1995-03-31
US5248695A (en) 1993-09-28
US5648386A (en) 1997-07-15
FI912151A0 (fi) 1991-05-03
CZ286389B6 (cs) 2000-03-15
CA2041818C (en) 2003-02-11
CA2041818A1 (en) 1991-11-05
EP0589488B1 (de) 1997-09-17
IL98030A0 (en) 1992-06-21
NZ238032A (en) 1996-02-27
DE59108853D1 (de) 1997-10-23
SK279258B6 (sk) 1998-08-05
IE80651B1 (en) 1998-11-04
EP0455155A1 (de) 1991-11-06
AU7611191A (en) 1991-11-07
NO911746D0 (no) 1991-05-03
EP0455155B1 (de) 1995-07-12
ATE158277T1 (de) 1997-10-15
TW197415B (es) 1993-01-01
PT97544A (pt) 1992-01-31
ATE124932T1 (de) 1995-07-15
NO911746L (no) 1991-11-05
NO174803B (no) 1994-04-05
EP0589488A1 (de) 1994-03-30
US5292753A (en) 1994-03-08
KR0183024B1 (ko) 1999-05-15
ZA913337B (en) 1993-01-27
HU911502D0 (en) 1991-11-28
US5395957A (en) 1995-03-07
JPH04225944A (ja) 1992-08-14
FI109600B (fi) 2002-09-13
IE69017B1 (en) 1996-07-24
KR910019966A (ko) 1991-12-19
IE911507A1 (en) 1991-11-06
GR3017064T3 (en) 1995-11-30
DE4014252A1 (de) 1991-11-07
SG45439A1 (en) 1998-01-16
AU645313B2 (en) 1994-01-13
BG94342A (en) 1994-06-30
NO174803C (es) 1994-07-13
ID966B (id) 1996-09-30
IL98030A (en) 1995-12-31
DK0589488T3 (da) 1998-05-04
HUT60999A (en) 1992-11-30
ES2075255T3 (es) 1995-10-01
BG60743B1 (bg) 1996-02-29
DK0455155T3 (da) 1995-11-13
HU214335B (hu) 1998-03-02
PT97544B (pt) 1998-08-31
GR3025547T3 (en) 1998-03-31
CS129291A3 (en) 1991-11-12
JP2944777B2 (ja) 1999-09-06
FI912151A (fi) 1991-11-05
DE59105957D1 (de) 1995-08-17
RU2002737C1 (ru) 1993-11-15

Similar Documents

Publication Publication Date Title
ES2109412T3 (es) (-)-cimaterol en esencia opticamente puro y sus sales por adicion de acidos, asi como su empleo como medicamento o favorecedor del rendimiento.
ATE135221T1 (de) Pharmazeutischer kaugummi mit acetylsalicylsäure
AR023719A1 (es) N-(glicilsustituidas)-2-ciano-pirrolidinas, una composicion farmaceutica y el uso de las mismas para la fabricacion de un medicamento
BR0207726A (pt) Sais farmacêuticos
ES2178779T3 (es) Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores.
ATE93511T1 (de) L-carnitin-magnesium-zitrat.
ES2032865T3 (es) Procedimiento para un tratamiento hidratante de la piel.
ES2063499T3 (es) Procedimiento para la preparacion del acido cis-beta-fenilglicidico-(2r,3r).
ES2053856T3 (es) Derivados del acido 4-quinoleino carboxilico utiles para el tratamiento de enfermedades de la piel y del muco-epitelio.
ES2061218T3 (es) Composiciones farmaceuticas estabilizadas.
ATE190498T1 (de) Stabile, pharmazeutische zusammensetzungen die hybrid alpha-interferon enthalten
IT1251226B (it) Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego
ES535694A0 (es) Procedimiento para la fabricacion de derivados del acido benzoico con actividad antimicrobiana
FR2376661A1 (fr) Medicaments anthelminthiques renfermant comme substances actives des anilinomethylene-malononitriles
ES2062001T3 (es) Procedimiento para la produccion de acidos grasos que tienen un alto grado de insaturacion.
MX9200288A (es) Procedimiento para la preparacion del acido 1,2,3,4-tetrahidroisoquinolin-3-carboxilico racemico y opticamente activo asi como sus productos previos.
ES2049700T3 (es) Sal de la s-carboximetilcisteina lisina monohidratada y procedimiento para su fabricacion.
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
IT1149212B (it) Medicinale a base di acido acetilsalicilico e di eptaminolo e composizione farmaceutica che lo comprende
MX9200977A (es) Proceso para producir l-lisina por fermentacion.
ES2050627B1 (es) Nuevo glutaraldehido activado y sinergizado.
JPS53130419A (en) Stabilized prostaglandin composition
MX9302928A (es) Bencilaminas substituidas en posicion para y medios terapeuticos que las contienen.
GB1113803A (en) Improvements in or relating to substituted quinolines and the manufacture thereof
ES2106689B1 (es) Nueva formulacion a base de acido hidroxicitrico (sales y derivados) y sus aplicaciones cosmeticas y farmaceuticas por via topica percutanea.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 589488

Country of ref document: ES